RN

Rinamkumar Nalinkumar Shah

Active Director Director DIN 02538252
DIN 02538252 First appointment Jul 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2004
Shareholding value •••• Premium profile

About Rinamkumar Nalinkumar Shah

Data last updated:

Rinamkumar Nalinkumar Shah is a Director at Mc Coy Drugs Private Limited (since 2004). The company operates in Pharma. Mc Coy Drugs Private Limited reported revenue of ₹11.59 Cr (FY 2025).

DIN 02538252
Primary Designation Director
Industry Pharma
First Appointment 01 Jul 2004
Oldest Company Age 22 yrs
Largest company Mc Coy Drugs Private Limited · ₹11.59 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mc Coy Drugs Private Limited U24230GJ2004PTC098840
Director01 Jul 20042004₹11.59 Cr (FY 2025)Active

Board colleagues of Rinamkumar Nalinkumar Shah

Directorship timeline

Open interactive timeline →
Mc Coy Drugs Private Limited
Premium access

Shareholding and investment profile for Rinamkumar Nalinkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rinamkumar Nalinkumar Shah

Rinamkumar Nalinkumar Shah currently holds 1 directorship: Mc Coy Drugs Private Limited (Director, since 01 Jul 2004, revenue ₹11.59 Cr (FY 2025)).

Rinamkumar Nalinkumar Shah was first appointed on 01 Jul 2004 as Director at Mc Coy Drugs Private Limited.

The current boards of Rinamkumar Nalinkumar Shah's companies include Mehul Satish Choksi (Mc Coy Drugs Private Limited), Nihar Shah (Mc Coy Drugs Private Limited), Suken Dineshchandra Shah (Mc Coy Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available